Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxocobalamin Approach for Reducing of Calprotectin With Butyrate for Ulcerative

NCT04259060 is registered in ClinicalTrials.gov with Joshua Korzenik as lead sponsor.

NCT NCT04259060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04259060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxocobalamin Approach for Reducing of Calprotectin With Butyrate for Ulcerative
Lead sponsor
Joshua Korzenik
Phase
Phase 2
Overall status
Withdrawn
Start date
January 31, 2024
Completion date
October 31, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis